These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

110 related items for PubMed ID: 8830016

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. RadD Contributes to R-Loop Avoidance in Sub-MIC Tobramycin.
    Negro V, Krin E, Aguilar Pierlé S, Chaze T, Giai Gianetto Q, Kennedy SP, Matondo M, Mazel D, Baharoglu Z.
    mBio; 2019 Jul 02; 10(4):. PubMed ID: 31266870
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. [Tobramycin, a new aminoglycoside antibiotic].
    Periti P, Serra E.
    G Ital Chemioter; 1973 Jul 02; 20(1-4):15-9. PubMed ID: 4156968
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. In vitro activity of moxalactam against pathogenic bacteria and its comparison with other antibiotics.
    Perrymann F, Flournoy DJ, Qadri SM.
    Chemotherapy; 1983 Jul 02; 29(1):37-42. PubMed ID: 6219865
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. A comparison of the in vitro activity of tobramycin and gentamicin against 6,042 clinical isolates.
    Melby K, Midtvedt T, Dahl O.
    Chemotherapy; 1979 Jul 02; 25(5):286-95. PubMed ID: 113179
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Antibacterial activity of tobramycin against gram-negative bacteria and the combination of ampicillin/tobramycin against E. coli.
    Laxer RM, Mackay E, Marks MI.
    Chemotherapy; 1975 Jul 02; 21(2):90-8. PubMed ID: 168040
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Susceptibility to tobramycin determined by a modified agar dilution method with a high inoculum.
    Santanam P.
    Eur J Clin Microbiol; 1985 Dec 02; 4(6):600-1. PubMed ID: 3912181
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Activity of Cysteamine against the Cystic Fibrosis Pathogen Burkholderia cepacia Complex.
    Fraser-Pitt D, Mercer D, Lovie E, Robertson J, O'Neil D.
    Antimicrob Agents Chemother; 2016 Oct 02; 60(10):6200-6. PubMed ID: 27503654
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.